Wu Li-Qun, Payne Gregory F
Center for Biosystems Research, University of Maryland Biotechnology Institute, 5115 Plant Sciences Building, College Park, MD 20742, USA.
Trends Biotechnol. 2004 Nov;22(11):593-9. doi: 10.1016/j.tibtech.2004.09.008.
Emerging opportunities are placing greater demands on device fabrication: next-generation microelectronics will need minimum features of less than 100 nm, high-throughput drug screening will require facile methods to incorporate sensitive biological components into microelectromechanical systems (MEMS), and implantable devices will need to be built from biocompatible materials. Increasingly, these emerging demands are being addressed by combining traditional microfabrication methods with 'biofabrication': namely, the use of biologically derived materials and biocatalysts. Recent fabrication techniques are using biological construction materials as process aids or structural components, and enzymes are being considered for their potential to fabricate devices with high selectivity under mild conditions. If incompatibilities between biology and microfabrication can be eliminated, then biofabrication will be poised to emerge as the standard for nanoscale construction.
下一代微电子器件将需要最小特征尺寸小于100纳米,高通量药物筛选将需要简便方法将敏感生物成分整合到微机电系统(MEMS)中,而可植入设备将需要由生物相容性材料制成。这些新出现的需求越来越多地通过将传统微制造方法与“生物制造”相结合来解决:即使用生物衍生材料和生物催化剂。最近的制造技术将生物建筑材料用作工艺辅助材料或结构部件,并且正在考虑利用酶在温和条件下制造具有高选择性的器件的潜力。如果能够消除生物学与微制造之间的不相容性,那么生物制造将有望成为纳米级制造的标准。